IMS Health's Social Media Analytics Solution Named a Leader by IDC MarketScape
March 27 2015 - 6:05PM
Business Wire
IMS Health (NYSE:IMS) has been named a leader in IDC Health
Insights’ assessment of social media and analytics software and
services offerings available to the life sciences industry. The
report, IDC MarketScape: Worldwide Life Science Social Media
Analytics 2014 Vendor Assessment (doc # HI252646, December 2014),
names IMS Health as a leader for Nexxus™ Social, its best-in-class
SaaS solution that monitors and integrates information from tens of
millions of social media sources worldwide — providing structure
and insights that can be used by life sciences companies to inform
key regulatory compliance and commercial decision-making
processes.
The IDC MarketScape report points out that Nexxus Social
supports 52 languages and includes “some of the most life
science–specific functionality available in social media analytics
software today by any vendor, and is considered by its customers to
be very user friendly and easy to use.” The report also cites IMS
Health’s industry-specific expertise, strong customer references
and proven expertise in delivering measurable value to clients. The
findings were based on a six-month evaluation of social media
analytics software and service offerings.
“Life science companies view social media analytics as an
effective tool for investigating competitive pricing and
promotions, evaluating therapeutic category of consumer trends and
related products, and measuring corporate- and brand-specific
consumer perceptions,” said Eric Newmark, program director of IDC
Health Insights’ Life Science Business Systems Strategy service.
“While dozens of vendors offer these services, few have true proven
success in delivering it.”
Nexxus Social, part of IMS Health’s NexxusTM Commercial
Application Suite, automates social media monitoring and evaluation
of social media content, helping to transform this new source of
unstructured data into actionable insights. Its algorithms use
semantic — not keyword — search and proprietary ontologies,
including patient language and Natural Language Processing (NLP),
to capture patient and physician perceptions of treatments on
social networks. The ability to quickly and efficiently harness and
act on social media insights can be a significant advantage in
developing enhanced patient engagement and clinical programs to
improve health outcomes.
“Scanning the digital landscape, listening to patients and
taking actions based on more timely insights have become critical
elements of commercial strategies for the life sciences industry.
We’re pleased to be recognized as a leader in this space by IDC
MarketScape,” said Siva Nadarajah, general manager, Social Media,
IMS Health.
For highlights of the IDC MarketScape report, click here. More
information about Nexxus Social can be found on the IMS Health
website.
About IMS Health
IMS Health is a leading global information and technology
services company providing clients in the healthcare industry with
comprehensive solutions to measure and improve their performance.
By applying sophisticated analytics and proprietary application
suites hosted on the IMS One™ intelligent cloud, the company
connects more than 10 petabytes of complex healthcare data on
diseases, treatments, costs and outcomes to help its clients run
their operations more efficiently. More than 10,000 employees drive
results for over 5,000 healthcare clients across 100 countries,
drawing on information from 100,000 suppliers and insights from
more than 55 billion healthcare transactions processed annually.
Customers include pharmaceutical, consumer health and medical
device manufacturers and distributors, providers, payers,
government agencies, policymakers, researchers and the financial
community.
As a global leader in protecting individual patient privacy, IMS
Health uses anonymous healthcare data to deliver critical,
real-world disease and treatment insights. These insights help
biotech and pharmaceutical companies, medical researchers,
government agencies, payers and other healthcare stakeholders to
identify unmet treatment needs and understand the effectiveness and
value of pharmaceutical products in improving overall health
outcomes. Additional information is available at
www.imshealth.com.
About IDC MarketScape
IDC MarketScape vendor analysis model is designed to provide an
overview of the competitive fitness of ICT (information and
communications technology) suppliers in a given market. The
research methodology utilizes a rigorous scoring methodology based
on both qualitative and quantitative criteria that results in a
single graphical illustration of each vendor’s position within a
given market. IDC MarketScape provides a clear framework in which
the product and service offerings, capabilities and strategies, and
current and future market success factors of IT and
telecommunications vendors can be meaningfully compared. The
framework also provides technology buyers with a 360-degree
assessment of the strengths and weaknesses of current and
prospective vendors.
IMS HealthTor Constantino, +1
484-567-6732tconstantino@us.imshealth.com
IMS HEALTH HOLDINGS, INC. (NYSE:IMS)
Historical Stock Chart
From Mar 2024 to Apr 2024
IMS HEALTH HOLDINGS, INC. (NYSE:IMS)
Historical Stock Chart
From Apr 2023 to Apr 2024